Remove Communication Remove Compounding Pharmacies Remove Diabetes
article thumbnail

STAT+: Pharmalittle: We’re reading about Novo and GLP-1 compounding, Paxlovid and long Covid, and more

STAT

Food and Drug Administration seeking to block compounding pharmacies in the U.S. The latest attempt focuses on liraglutide, an older, once-daily injectable product sold as Victoza and Xultophy for diabetes and Saxenda for obesity. … Novo Nordisk filed another citizen’s petition with the U.S.

article thumbnail

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

Pharmacy Times

CPAs are essentially signed contracts that have formal agreements with well-defined scopes, which allow for collaboration and communication among health care professionals in areas lacking aspects of health care, according to Klepser. This is where collaborative practice agreements (CPAs) come in.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Pharmacy Times

The findings highlight that there remain communication gaps between oncology providers and patients and that opportunities exist for pharmacists to counsel newly diagnosed oncology patients on their fertility preservation options.

article thumbnail

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Pharmacy Times

If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider. Results American Oncology Network (AON) Pharmacy collected data on waste and cost avoidance from February 2023 to September 2023.

article thumbnail

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Pharmacy Times

We are communicating this information now to allow time for patients to work closely with their health care teams to develop alternative treatment plans.” Takeda has informed the FDA that the manufacturing of Gammagard S/D will cease in December 2027.

article thumbnail

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pharmacy Times

These job duties each require different skill sets, from writing and verbal communication to process development, technical aptitude, and deep clinical expertise. Someone adept at all these skills simultaneously is called a unicorn—and unicorns are rare in oncology pharmacy, if they exist at all.

article thumbnail

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

Pharmacy Times

Designed to manage patients with complex, chronic neurological conditions such as multiple sclerosis (MS), epilepsy, migraine, and movement disorders, the model aims to enhance medication access, streamline communication, and improve clinical outcomes.